PPH icon

VanEck Pharmaceutical ETF
PPH

Overview Fund Activity

48 hedge funds and large institutions have $136M invested in VanEck Pharmaceutical ETF in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
-2
Holders Change %
-4%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
17
Closed
5
Calls
$312K
Puts
$445K
Net Calls
-$133K
Net Calls Change
+$180K

Top Buyers

1
Bank of America
1
Bank of America
North Carolina
$70.6M
2
SG Americas Securities
2
SG Americas Securities
New York
$5.99M
3
BCI
3
Brinker Capital Investments
Pennsylvania
$1.27M
4
UBS Group
4
UBS Group
Switzerland
$6.98M
5
WI
5
Wintrust Investments
Illinois
$780K

Top Sellers

1
RJFSA
1
Raymond James Financial Services Advisors
Florida
$336K
2
SCM
2
Stuyvesant Capital Management
New York
$0
3
TRCT
3
Tower Research Capital (TRC)
New York
$27K
4
SB
4
Suntrust Banks
Georgia
$0
5
VF
5
Virtu Financial
New York
$204K
Name Holding Trade Value Shares
Change 		Shares
Change %
Creative Planning
51
Creative Planning
Kansas
– -$139K -2,360 Closed
WEC
52
Winslow Evans & Crocker
Massachusetts
– -$5.91K -100 Closed
1 2
3